top of page

T32 Research Grant

Research at the University of Pittsburgh is funded by the National Institute of Health T32 Research Grant. We offer an extensive array of research areas to choose from to meet the interests of the applicant, whether it be basic, clinical or translational research. Salary is commensurate with post-graduate level.

Applicants must have a doctorate degree and be either a United States citizen or permanent resident (due to the nature of the grant).

To apply for July 1, 2024 start date, please send

CV and cover letter to

Amanda Pippi at hickeyab2@upmc.edu

Join our leading researchers in cancer care for individualized training at one of the best hospitals in the country. Our research is consistently innovative and world-renowned, improving countless lives.

Research Mentors

jz trial_edited.png

Jose Zevallos, MD, MPH

Ferris V2_edited.png

Robert L. Ferris, MD, PhD

T32 Delgoffe 5_edited.png

Greg M. Delgoffe, PhD

T32 Diergaarde_Brenda_edited.png

Brenda Diergaarde, PhD

T32 Nikiforov 2.jpg

Yuri Nikiforov, MD, PhD

T32 Osmanbeyolgu 2.jpg

Hatice Osmanbeyoglu, PhD

T32 Scheff.jpg

Nicole Scheff, PhD

Skinner V2_edited.png

Heath Skinner, Md, PhD

T32 K. Smith 2.png

Kenneth J. Smith, MD, PhD

T32 Vignali.png

Dario A. Vignali, PhD

Jing-H_Wang-.jpg

Jing Hong Wang, MD, PhD

T32 whiteside.png

Theresa L. Whiteside, PhD

bruno-headshot_edited.jpg

Tullia C. Bruno, PhD

hillman.jpg

Hillman Cancer Center

Assembly.jpg

The Assembly

T32 Flyer for 2024 Start.PNG

T32 Research Fellowship

Areas of Research

Head and Neck Cancer

Oncologic Immunology

Oncologic Epidemiology

Disparities

Biostatistics

Molecular Biology

Genetics

Thyroid Pathology

Biomedical Informatics

Oncologic Neurobiology

Publications

Molkentine DP, Molkentine JM, Bridges KA, Valdecanas DR, Dhawan A, Bahri R, Hefner AJ, Kumar M, Yang L, Abdelhakiem M, Pifer PM, Sandulache V, Sheth A, Beadle BM, Thames HD, Mason KA, Pickering CR, Meyn RE, Skinner HD. p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade. Cancer Res. 2022 Mar 1;82(5):916-928. PMID: 34965932

Kulkarni S, Bill A, Godse NR, Khan NI, Kass JI, Steehler K, Kemp C, Davis K, Bertrand CA, Vyas AR, Holt DE, Grandis JR, Gaither LA, Duvvuri U. TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2. Genes Chromosomes Cancer. 2017 Jun;56(6):460-471.  Epub 2017 Apr 3. PMID: 28177558

Mady LJ, Grimes MC, Khan NI, Rao RH, Chiosea SI, Yip L, Ferris RL, Nikiforov YE, Carty SE, Duvvuri U. Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers. Sci Rep. 2020 May 15;10(1):8031. PMID: 32415114

bottom of page